MacroGenics (MGNX) announced that effective as of August 13, Eric Risser has been appointed president, CEO and to the board of directors. Risser has served as COO at MacroGenics since 2022. Risser succeeds Scott Koenig, who is stepping down after serving as president and CEO for the past 24 years.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MGNX:
- MGNX Earnings this Week: How Will it Perform?
- MacroGenics’ Prostate Cancer Study: A Potential Game-Changer?
- MacroGenics’ Phase 2 Study: A Potential Game-Changer in Prostate Cancer Treatment?
- MacroGenics’ Promising Study on Advanced Solid Tumors: Key Insights for Investors
- MacroGenics Advances Cancer Treatment with MGC026 Study Update